MANKINDNSEMankind Pharma LimitedLowNeutral
Announced Wed, 21 May · 10:49 IST

Allotment of 92,512 Equity Shares under Mankind Employee Stock Option Plan2022

Capital Market Events View source PDF

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Mankind Pharma has allotted 92,512 equity shares (face value Re. 1 each) to eligible employees who exercised their stock options under the Mankind Employee Stock Option Plan 2022. The exercise price was Rs. 860 per share, comprising Re. 1 face value and Rs. 859 premium. Following this allotment, the company's paid-up equity share capital increased from 41,25,78,527 to 41,26,71,039 shares. The newly issued shares carry equal rights with existing shares and have no lock-in period. This is a routine ESOP exercise disclosure filed under SEBI's share-based benefits regulations.

Likely market impact

This represents a very small dilution of about 0.02% to existing shareholders, with negligible effect on the stock price. The allotment reflects ongoing employee participation in the ESOP scheme and is a standard corporate action.